실적분석 2026년 8월 3일

Alexandria Real Estate Equities ($ARE) Q2 2026 Earnings Analysis — Revenue Slightly Beats, Full-Year FFO Midpoint Reaffirmed

Earnings Scorecard

Revenue: $663 million (-13.0% YoY, vs. $656 million estimate) ✅ Beat

EPS: GAAP net loss attributable to common shareholders of $0.43 per diluted share · Adjusted FFO of $1.73 per share (vs. $2.33 YoY). The $0.12 estimate (adjusted) cannot be directly compared due to different metric definitions and scale.

Guidance: Reaffirmed — Full-year 2026 adjusted FFO per share of $6.35–$6.45, midpoint $6.40 maintained (range narrowed from the prior $6.30–$6.50)

Stock reaction: +1.39% after-hours ($53.77) — as of 08-04 06:39 KST

The Positives

Slight revenue beat: Total revenue of $663 million edged past the $656 million estimate

Leasing rebound: Q2 total leasing of 1.039 million square feet, up roughly 60% from the prior quarter

Full-year midpoint maintained: Adjusted FFO per-share midpoint of $6.40 retained, with only the range narrowed

Alexandria is a real estate investment trust that leases research and development facilities to tenants clustered in life-sciences and high-tech hubs such as Boston, San Diego, and the San Francisco Bay Area. This quarter's total revenue (for the quarter ended June 30, 2026) was $662.78 million, down from $762.04 million a year earlier, but it cleared the $656 million consensus. In REIT scorecards, operating cash flow and leasing activity tend to matter more than a typical company's net income.

The leasing picture showed a clear rebound. Q2 total leasing volume came in at 1,038,917 square feet, up sharply from 647,356 square feet in Q1, with existing tenants accounting for roughly 75% of leasing activity over the trailing twelve months. In June, the company completed a build-to-suit lease with Bristol-Myers Squibb for a 426,927-square-foot research and development hub, beginning to roll in approximately $57 million of incremental annual net operating income.

A message of financial stability came through as well. The company highlighted balance-sheet cushion, including roughly $3.6 billion in liquidity, an extension of its unsecured credit facility maturity (to 2032), and a weighted-average remaining debt maturity of 9.7 years. By holding the full-year adjusted FFO guidance midpoint steady while narrowing only the range, management left the impression that visibility into the second half has improved modestly.

The Negatives

Sharp YoY drop in operating cash flow: Adjusted FFO of $1.73 per share (vs. $2.33 YoY), a decline of roughly 26%

Weaker occupancy and same-store results: Operating portfolio occupancy of 86.9%, same-store NOI of -10.6%

Negative renewal spreads: Cash rental rate change on renewals and re-leasing of -4.3%, with vacancy gaps persisting

The heaviest number is the erosion in earnings power. Adjusted FFO attributable to common shareholders totaled $296.1 million in Q2, or $1.73 per share, down sharply from $396.4 million, or $2.33 per share, a year earlier. On a GAAP basis, items including approximately $222.47 million of real estate impairment charges drove a net loss attributable to common shareholders of $73.7 million, or $0.43 per diluted share. While the loss narrowed from a $0.64 per-share loss a year earlier, the decline in cash-flow metrics is the more fundamental weakness.

Occupancy and rental rates do not yet appear to have found a floor either. Operating portfolio occupancy slipped from 87.7% at the end of March to 86.9% at the end of June, and even including leased-but-not-yet-occupied space it sits at only around 90.9%. Same-store net operating income fell 10.6% year over year (8.6% on a cash basis), which management attributed to the impact of previously disclosed major move-out expirations (roughly 920,000 square feet combined in Q1 and Q2).

Pricing power also looked weaker in renewal negotiations. Rental rate change on Q2 renewals and re-leasing was -0.7%, or -4.3% on a cash basis. On top of this, the company continues to assume an annualized drag of $25–30 million on FFO from deferred rent amortization and reserves tied to tenant bankruptcy matters, making the pace at which vacant space is backfilled and the terms of renewals the key second-half watchpoints.

What Management Said

Management reiterated full-year 2026 adjusted FFO per-share guidance of $6.35–$6.45, holding the $6.40 midpoint unchanged from the prior quarter (April 27). Narrowing the range by 10 cents can be read as modestly improved visibility into the full-year picture, but it is closer to a defensive tightening of the uncertainty band than a signal of accelerating growth. Management attributed the ability to preserve the midpoint to the offsetting impact of delayed gains from capital-recycling activity, even as the weighted-average completion timing for asset sales and partial-interest monetizations was pushed back by roughly six weeks — from August to September — which is expected to increase interest expense and reduce capitalized interest.

Management also indicated that Q4 adjusted FFO is likely to come in toward the lower end of the previously issued and reaffirmed $1.40–$1.50 per-share range. Five development and redevelopment projects (totaling roughly 1.4 million square feet) remain under review for continued lab use, construction pause, lower-cost conversion to high-tech use, or sale, and the company is already trimming capital spending — for example, by converting a portion of the Minuteman Road property in Boston to high-tech tenancy, cutting project costs by roughly $80 million. The dividend was held at $0.72 per common share, in line with the prior quarter, and the $500 million share-repurchase authorization remained unused as of the end of June.

Market Reaction and What to Watch

The market appears to have interpreted the print as a package — a modest revenue beat, reaffirmed full-year midpoint, rebound in leasing volume, and ample liquidity — rather than focusing on the year-over-year decline in operating cash flow. With concerns about life-sciences office and lab vacancies already substantially priced into the stock, the "not getting worse" confirmation, combined with the capital-recycling and debt-paydown roadmap, appears to have drawn some modest relief buying. However, the persistent same-store decline and negative renewal spreads kept the reaction in check.

Whether the share of the already-leased 1.4 million square feet that actually moves in by year-end tracks the company's assumption (roughly 64%)

Whether execution of the full-year $2.9 billion midpoint for capital-recycling proceeds (asset sales and partial-interest monetizations) proceeds as planned in the second half

Whether, as Q4 adjusted FFO tilts toward the lower end of the $1.40–$1.50 per-share range, occupancy and renewal terms improve in tandem